Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Bozena Kaminska, Mariana Mota, Marina Pizzi

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Activation of microglia is a common denominator and a pathophysiological hallmark of the central nervous system (CNS) disorders. Damage or CNS disorders can trigger inflammatory responses in resident microglia and initiate a systemic immune system response. Although a repertoire of inflammatory responses differs in those diseases, there is a spectrum of transcriptionally activated genes that encode various mediators such as growth factors, inflammatory cytokines, chemokines, matrix metalloproteinases, enzymes producing lipid mediators, toxic molocules, all of which contribute to neuroinflammation. The initiation, progression and termination of inflammation requires global activation of gene expression, postranscriptional regulation, epigenetic modifications, changes in chromatin structure and these processes are tightly regulated by specific signaling pathways. This review focuses on the function of "master regulators" and epigenetic mechanisms in microglia activation during neuroinflammation. We review studies showing impact of epigenetic enzyme inhibitors on microglia activation in vitro and in vivo, and critically discuss potential of such molecules to prevent/moderate pathological events mediated by microglia under brain pathologies. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.

Original languageEnglish
Pages (from-to)339-351
Number of pages13
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1862
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Microglia
Epigenomics
Signal Transduction
Central Nervous System Diseases
Inflammation
Poisons
Gene Expression Regulation
Enzyme Inhibitors
Matrix Metalloproteinases
Chemokines
Chromatin
Immune System
Intercellular Signaling Peptides and Proteins
Pathology
Cytokines
Lipids
Brain
Enzymes
Genes

Keywords

  • Epigenetics
  • HDAC inhibitors
  • Microglia
  • Neuroinflammation
  • Signaling pathways
  • Transcription regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation. / Kaminska, Bozena; Mota, Mariana; Pizzi, Marina.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, No. 3, 01.03.2016, p. 339-351.

Research output: Contribution to journalArticle

@article{3a0b3734659a4a5ea73250905f54c465,
title = "Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation",
abstract = "Activation of microglia is a common denominator and a pathophysiological hallmark of the central nervous system (CNS) disorders. Damage or CNS disorders can trigger inflammatory responses in resident microglia and initiate a systemic immune system response. Although a repertoire of inflammatory responses differs in those diseases, there is a spectrum of transcriptionally activated genes that encode various mediators such as growth factors, inflammatory cytokines, chemokines, matrix metalloproteinases, enzymes producing lipid mediators, toxic molocules, all of which contribute to neuroinflammation. The initiation, progression and termination of inflammation requires global activation of gene expression, postranscriptional regulation, epigenetic modifications, changes in chromatin structure and these processes are tightly regulated by specific signaling pathways. This review focuses on the function of {"}master regulators{"} and epigenetic mechanisms in microglia activation during neuroinflammation. We review studies showing impact of epigenetic enzyme inhibitors on microglia activation in vitro and in vivo, and critically discuss potential of such molecules to prevent/moderate pathological events mediated by microglia under brain pathologies. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.",
keywords = "Epigenetics, HDAC inhibitors, Microglia, Neuroinflammation, Signaling pathways, Transcription regulation",
author = "Bozena Kaminska and Mariana Mota and Marina Pizzi",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.bbadis.2015.10.026",
language = "English",
volume = "1862",
pages = "339--351",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

AU - Kaminska, Bozena

AU - Mota, Mariana

AU - Pizzi, Marina

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Activation of microglia is a common denominator and a pathophysiological hallmark of the central nervous system (CNS) disorders. Damage or CNS disorders can trigger inflammatory responses in resident microglia and initiate a systemic immune system response. Although a repertoire of inflammatory responses differs in those diseases, there is a spectrum of transcriptionally activated genes that encode various mediators such as growth factors, inflammatory cytokines, chemokines, matrix metalloproteinases, enzymes producing lipid mediators, toxic molocules, all of which contribute to neuroinflammation. The initiation, progression and termination of inflammation requires global activation of gene expression, postranscriptional regulation, epigenetic modifications, changes in chromatin structure and these processes are tightly regulated by specific signaling pathways. This review focuses on the function of "master regulators" and epigenetic mechanisms in microglia activation during neuroinflammation. We review studies showing impact of epigenetic enzyme inhibitors on microglia activation in vitro and in vivo, and critically discuss potential of such molecules to prevent/moderate pathological events mediated by microglia under brain pathologies. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.

AB - Activation of microglia is a common denominator and a pathophysiological hallmark of the central nervous system (CNS) disorders. Damage or CNS disorders can trigger inflammatory responses in resident microglia and initiate a systemic immune system response. Although a repertoire of inflammatory responses differs in those diseases, there is a spectrum of transcriptionally activated genes that encode various mediators such as growth factors, inflammatory cytokines, chemokines, matrix metalloproteinases, enzymes producing lipid mediators, toxic molocules, all of which contribute to neuroinflammation. The initiation, progression and termination of inflammation requires global activation of gene expression, postranscriptional regulation, epigenetic modifications, changes in chromatin structure and these processes are tightly regulated by specific signaling pathways. This review focuses on the function of "master regulators" and epigenetic mechanisms in microglia activation during neuroinflammation. We review studies showing impact of epigenetic enzyme inhibitors on microglia activation in vitro and in vivo, and critically discuss potential of such molecules to prevent/moderate pathological events mediated by microglia under brain pathologies. This article is part of a Special Issue entitled: Neuro Inflammation edited by Helga E. de Vries and Markus Schwaninger.

KW - Epigenetics

KW - HDAC inhibitors

KW - Microglia

KW - Neuroinflammation

KW - Signaling pathways

KW - Transcription regulation

UR - http://www.scopus.com/inward/record.url?scp=84957861141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957861141&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2015.10.026

DO - 10.1016/j.bbadis.2015.10.026

M3 - Article

AN - SCOPUS:84957861141

VL - 1862

SP - 339

EP - 351

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 3

ER -